Skip to main content
. 2019 Oct 9;32(6):989–1001. doi: 10.1007/s40620-019-00656-5

Table 6.

Safety endpoints according to study allocation

Sodium bicarbonate Standard care
Baseline Follow-up p value Baseline Follow up
Mean systolic blood pressure mmHg (SD) 129 (19) 127 (16) 0.147 128 (18) 127 (15)
Mean systolic blood pressure change mmHg − 1.5 (19.8) − 1.2 (10.9)
Mean diastolic blood pressure mmHg (SD) 73 (8) 74 (9) 0.202 74 (11) 76 (10)
Mean diastolic blood pressure change mmHg − 3.0 (11.0) − 2.5 (10.1)
Prevalence of systolic blood pressure N (%)
 > 145 mmHg 53 (23.3) 36 (11.0) 0.001 86 (25.7) 52 (15.6)
 135–145 mmHg 51 (15.6) 49 (15.0) 0.916 34 (10.2) 61 (18.3)
 < 100 mmHg 32 (9.8) 19 (5.8) 0.077 17 (5.1) 11 (3.3)
Prevalence of diastolic blood pressure N (%)
 > 85 mmHg 28 (8.6) 25 (7.6) 0.743 10 (3.0) 8 (2.4)
Serum albumin (g/dl) 3.8 (0.4) 3.9 (0.4) 0.005 3.8 (0.4) 3.8 (0.5)
Serum hemoglobin (g/dl) 12.2 (1.8) 12.4 (2.1) 0.499 12.4 (1.7) 12.3 (1.8)
Serum potassium (mmol/l) 4.9 (0.5) 4.9 (0.6) 0.518 4.9 (0.6) 4.9 (0.7)
24 h urine sodium (mmol/l) 157 (41) 154 (23) 0.384 173 (44) 159 (41)
24 h chloride (mmol/l) 128 (22) 98 (21) 0.001 124 (20) 119 (24)
Body weight (kg) 74.7 (13.0) 74.0 (11.7) 0.467 75.6 (9.7) 74.9 (11.7)

The mean (standard deviation) of baseline as well as the last available data at follow-up is reported. Complete cases are reported and no missing data imputation is performed